Showing results (191-200 of 229) with videos related to
Sort By:
Pageof 23
Cephalalgia : an International Journal of Headache|January 15, 2013
Stimulation of the sphenopalatine ganglion (SPG) for cluster headache treatment. Pathway CH-1: a randomized, sham-controlled studyJean Schoenen, Rigmor Højland Jensen, Michel Lantéri-Minet, et al.Neurology|November 17, 2022
Effect of Atogepant for Preventive Migraine Treatment on Patient-Reported Outcomes in the Randomized, Double-blind, Phase 3 ADVANCE TrialRichard B Lipton, Patricia Pozo-Rosich, Andrew M Blumenfeld, et al.Cephalalgia : an International Journal of Headache|September 26, 2019
CGRP-dependent and independent mechanisms of acute and persistent post-traumatic headache following mild traumatic brain injury in miceEdita Navratilova, Jill Rau, Janice Oyarzo, et al.Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|February 5, 2015
Value of intra- and post-operative cone beam computed tomography (CBCT) for positioning control of a sphenopalatine ganglion neurostimulator in patients with chronic cluster headacheAlexandre T Assaf, Jan C Klatt, Marco Blessmann, et al.Cephalalgia : an International Journal of Headache|May 12, 2016
Long-term effectiveness of sphenopalatine ganglion stimulation for cluster headacheTim P Jürgens, Mads Barloese, Arne May, et al.Cephalalgia : an International Journal of Headache|October 27, 2010
Topiramate intervention to prevent transformation of episodic migraine: the topiramate INTREPID studyRichard B Lipton, Stephen Silberstein, David Dodick, et al.Journal of Medical Economics|March 25, 2018
Estimating the clinical effectiveness and value-based price range of erenumab for the prevention of migraine in patients with prior treatment failures: a US societal perspectiveRichard B Lipton, Alan Brennan, Stephen Palmer, et al.The Journal of Headache and Pain|April 25, 2025
Increased infection risk in patients on preventive CGRP-targeting therapies- a meta-analysis and clinical effect assessmentMarcin Straburzyński, Daria Kopyt, Karol Marschollek, et al.Neurology|August 25, 2017
Erenumab (AMG 334) in episodic migraine: Interim analysis of an ongoing open-label studyMessoud Ashina, David Dodick, Peter J Goadsby, et al.Headache|September 2, 2009
Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measuresStephen Silberstein, Richard Lipton, David Dodick, et al.Pageof 23